Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126595801	12659580	1	I	20151210	20160810	20160817	20160817	EXP		CN-PFIZER INC-2016386724	PFIZER		77.00	YR		F	Y	52.00000	KG	20160817		OT	CN	CN

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126595801	12659580	1	PS	LIPITOR	ATORVASTATIN CALCIUM	1	Oral	20 MG, 1X/DAY	600	MG	Y	M30562	20702	20	MG	FILM-COATED TABLET	QD
126595801	12659580	2	SS	AVELOX	MOXIFLOXACIN HYDROCHLORIDE	1	Intravenous drip	250 ML, 1X/DAY	4500	ML	Y		0	250	ML	INJECTION	QD
126595801	12659580	3	SS	AVELOX	MOXIFLOXACIN HYDROCHLORIDE	1	Intravenous drip	250 ML, 1X/DAY	4500	ML	Y	BXH6AB3	0	250	ML	INJECTION	QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126595801	12659580	1	Lipids abnormal
126595801	12659580	2	Lung disorder

Outcome of event

Event ID	CASEID	OUTC COD
126595801	12659580	DS
126595801	12659580	OT

Reactions reported

Event ID	CASEID	PT
126595801	12659580	Blood creatine phosphokinase MB increased
126595801	12659580	Blood creatine phosphokinase increased
126595801	12659580	Blood creatinine increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
126595801	12659580	1	20151111	20151213
126595801	12659580	2	20151117	20151125
126595801	12659580	3	20151202	20151211